Anna Martha Vaitses Fontanari1, Gabriel Ibarra Zanella2, Marina Feijó2, Siobhan Churchill3, Maria Inês Rodrigues Lobato4, Angelo Brandelli Costa2. 1. Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Electronic address: avaitses@uwo.ca. 2. Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. 3. Western University, London, Ontario, Canada. 4. Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Abstract
RATIONALE: Transgender people face unique challenges, such as structural, interpersonal, and individual vulnerabilities to chronic diseases. Stigma and prejudice may hamper their access to health care and prevent their inclusion in the labor market, as well as cause exposition to violence. Labor market exclusion contributes to engagement in survival sex work, which increases HIV infection vulnerability. HIV continuum of care combines HIV prevention (including antiretroviral pre-exposure prophylaxis (PrEP), antiretroviral post-exposure prophylaxis (PEP) and HIV testing) with linkage to care (that is, initiating, maintaining and monitoring antiretroviral therapy). Currently, many studies evaluate the access barriers and facilitators to HIV care for transgender people. OBJECTIVE: The present systematic review aimed to provide a clear summary of the current literature on HIV-related care for transgender men, transgender women and gender diverse people. METHOD: Inclusion criteria were peer-reviewed quantitative studies, published through April 04, 2018, concerning transgender women, transgender men and gender diverse people and HIV-related care, which was any intervention aiming to prevent, treat or alleviate the impact of HIV on these populations. RESULTS: From 6,585 references, 62 articles were included: Three articles had results on PEP, 18 on PrEP, 29 on HIV-testing, 17 on access to health care, and 13 on adherence to treatment. CONCLUSIONS: The present study is the first systematic review evaluating HIV-related care for transgender people. Data collection is still scarce regarding transgender men and gender diverse people. Worldwide, testing for HIV infection does not necessarily enable access to the HIV continuum of care for transgender populations or even guarantee awareness of HIV seropositivity.
RATIONALE: Transgender people face unique challenges, such as structural, interpersonal, and individual vulnerabilities to chronic diseases. Stigma and prejudice may hamper their access to health care and prevent their inclusion in the labor market, as well as cause exposition to violence. Labor market exclusion contributes to engagement in survival sex work, which increases HIV infection vulnerability. HIV continuum of care combines HIV prevention (including antiretroviral pre-exposure prophylaxis (PrEP), antiretroviral post-exposure prophylaxis (PEP) and HIV testing) with linkage to care (that is, initiating, maintaining and monitoring antiretroviral therapy). Currently, many studies evaluate the access barriers and facilitators to HIV care for transgender people. OBJECTIVE: The present systematic review aimed to provide a clear summary of the current literature on HIV-related care for transgender men, transgender women and gender diverse people. METHOD: Inclusion criteria were peer-reviewed quantitative studies, published through April 04, 2018, concerning transgender women, transgender men and gender diverse people and HIV-related care, which was any intervention aiming to prevent, treat or alleviate the impact of HIV on these populations. RESULTS: From 6,585 references, 62 articles were included: Three articles had results on PEP, 18 on PrEP, 29 on HIV-testing, 17 on access to health care, and 13 on adherence to treatment. CONCLUSIONS: The present study is the first systematic review evaluating HIV-related care for transgender people. Data collection is still scarce regarding transgender men and gender diverse people. Worldwide, testing for HIV infection does not necessarily enable access to the HIV continuum of care for transgender populations or even guarantee awareness of HIV seropositivity.
Authors: Laura M Smeaton; Emma M Kileel; Beatriz Grinsztejn; Edward M Gardner; Kate Starr; Melissa L Murry; Patrice Desvigne-Nickens; Beverly Alston-Smith; Myron A Waclawiw; Katharine Cooper-Arnold; José V Madruga; Shashi Sangle; Kathleen V Fitch; Markella V Zanni; Pamela S Douglas; Heather J Ribaudo; Steven K Grinspoon; Karin L Klingman Journal: J Infect Dis Date: 2020-07-09 Impact factor: 5.226
Authors: Benedikt Pleuhs; Katherine G Quinn; Jennifer L Walsh; Andrew E Petroll; Steven A John Journal: AIDS Patient Care STDS Date: 2020-02-28 Impact factor: 5.078
Authors: Lila Starbuck; Sarit A Golub; Augustus Klein; Alexander B Harris; Amiyah Guerra; Christopher Rincon; Asa E Radix Journal: J Acquir Immune Defic Syndr Date: 2022-05-01 Impact factor: 3.771
Authors: Erin E Cooney; Sari L Reisner; Haneefa T Saleem; Keri N Althoff; S Wilson Beckham; Asa Radix; Christopher M Cannon; Jason S Schneider; J Sonya Haw; Allan E Rodriguez; Andrew J Wawrzyniak; Tonia C Poteat; Kenneth H Mayer; Chris Beyrer; Andrea L Wirtz Journal: Ann Epidemiol Date: 2022-04-06 Impact factor: 6.996
Authors: Jesse Clark; Sari Reisner; Amaya Perez-Brumer; Leyla Huerta; Hugo Sanchez; Kathleen Moriarty; Maria Mamani Luque; Hideaki Okochi; Ximena Salazar; Matthew Mimiaga; Jorge Sanchez; Monica Gandhi; Kenneth H Mayer; Javier R Lama Journal: AIDS Behav Date: 2021-01-01
Authors: Arjee J Restar; E Karina Santamaria; Alexander Adia; Jennifer Nazareno; Randolph Chan; Mark Lurie; Theo Sandfort; Laufred Hernandez; Susan Cu-Uvin; Don Operario Journal: PLoS One Date: 2019-10-21 Impact factor: 3.240
Authors: Ramiro Figueiredo Catelan; Alexandre Saadeh; Maria Inês Rodrigues Lobato; Daniel Augusto Mori Gagliotti; Angelo Brandelli Costa Journal: Int J Environ Res Public Health Date: 2021-05-01 Impact factor: 3.390